Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment.
Ontology highlight
ABSTRACT: Cancer progression and metastasis due to tumor immune evasion and drug resistance is strongly associated with immune suppressive cellular responses, particularly in the case of metastatic tumors. The myeloid cell component plays a key role within the tumor microenvironment (TME) and disrupts both adaptive and innate immune cell responses leading to loss of tumor control. Therefore, strategies to eliminate or modulate the myeloid cell compartment of the TME are increasingly attractive to non-specifically increase anti-tumoral immunity and enhance existing immunotherapies. This review covers current strategies targeting myeloid suppressor cells in the TME to enhance anti-tumoral immunity, including strategies that target chemokine receptors to deplete selected immune suppressive myeloid cell
SUBMITTER: Cao J
PROVIDER: S-EPMC10126309 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA